S-Adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: A double-blind cross-over trial. [ISRCTN36233495]
<p>Abstract</p> <p>Background</p> <p>S-Adenosylmethionine (SAMe) is a dietary supplement used in the management of osteoarthritis (OA) symptoms. Studies evaluating SAMe in the management of OA have been limited to Non Steroidal Anti-inflammatory Drugs (NSAIDs) for compa...
Main Authors: | Harvey Phillip W, Tobis Jerome S, Hoehler Fred, Reinsch Sibylle, Najm Wadie I |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2004-02-01
|
Series: | BMC Musculoskeletal Disorders |
Online Access: | http://www.biomedcentral.com/1471-2474/5/6 |
Similar Items
-
Structural mechanism of S-adenosyl methionine binding to catechol O-methyltransferase.
by: Douglas Tsao, et al.
Published: (2011-01-01) -
The Key Intermediate in Radical S‑Adenosyl-methionine Catalysis: Caught in the Act
by: Jonathan Rittle
Published: (2019-10-01) -
The Efficacy of S-Adenosyl Methionine and Probiotic Supplementation on Depression: A Synergistic Approach
by: Hammad Ullah, et al.
Published: (2022-07-01) -
Benzoxaborole treatment perturbs S-adenosyl-L-methionine metabolism in Trypanosoma brucei.
by: Pieter C Steketee, et al.
Published: (2018-05-01) -
Biosynthesis of S-adenosyl-methionine enhances aging-related defects in Drosophila oogenesis
by: Yoshiki Hayashi, et al.
Published: (2022-04-01)